Biologics and cell therapy programs are under increasing pressure to deliver high‑quality cell lines and physiologically meaningful 3D models—faster, more consistently, and with full traceability. Yet ...

Non-CHO cell expression systems gain traction as faster, more flexible alternatives for biologics manufacturing.

Cas9, Transcription Activator-Like Effector Nucleases (TALENs), and Zinc-Finger nucleases (ZFNs) have demonstrated great utility, primarily for genetic knock-out applications, none have been adopted ...

PHCbi will exhibit LiCellGrow™ at the 25th Congress of the Japanese Society for Regenerative Medicine, March 19-20 at the ...

LiCellGrow was developed to assist therapy developers in determining the optimal culture conditions during process ...

Proteomics-informed, genome-edited CHO design increased productivity up to three-fold and titers two-fold, strengthening CLD for novel biologics and biosimilars. Extended culture robustness was ...

A little over a year after winning manufacturing certification for its cell therapy factory-in-a-box, South San Francisco’s Cellares has passed another major production milestone. Cellares’ automated ...

ATW Technology has announced agreements with two leading solar manufacturers to upgrade their existing production lines with its innovative 0BB (zero busbar) stringer technology. The combined upgrade ...

It’s no secret that ion-exchange membranes are the real workhorses in gadgets like fuel cell technology, batteries, and ...